- Home
- NKTX vs QTRX Comparison
NKTX vs QTRX Comparison
Compare NKTX & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTX
- QTRX
- Stock Information
- Founded
- NKTX 2015
- QTRX 2007
- Country
- NKTX United States
- QTRX United States
- Employees
- NKTX N/A
- QTRX N/A
- Industry
- NKTX Biotechnology: Pharmaceutical Preparations
- QTRX Biotechnology: Laboratory Analytical Instruments
- Sector
- NKTX Health Care
- QTRX Industrials
- Exchange
- NKTX Nasdaq
- QTRX Nasdaq
- Market Cap
- NKTX 170.8M
- QTRX 201.7M
- IPO Year
- NKTX 2020
- QTRX 2017
- Fundamental
- Price
- NKTX $1.71
- QTRX $5.36
- Analyst Decision
- NKTX Strong Buy
- QTRX Strong Buy
- Analyst Count
- NKTX 6
- QTRX 4
- Target Price
- NKTX $15.00
- QTRX $18.25
- AVG Volume (30 Days)
- NKTX 2.5M
- QTRX 794.2K
- Earning Date
- NKTX 05-08-2025
- QTRX 05-06-2025
- Dividend Yield
- NKTX N/A
- QTRX N/A
- EPS Growth
- NKTX N/A
- QTRX N/A
- EPS
- NKTX N/A
- QTRX N/A
- Revenue
- NKTX N/A
- QTRX $137,421,000.00
- Revenue This Year
- NKTX N/A
- QTRX $5.22
- Revenue Next Year
- NKTX N/A
- QTRX $15.31
- P/E Ratio
- NKTX N/A
- QTRX N/A
- Revenue Growth
- NKTX N/A
- QTRX 12.30
- 52 Week Low
- NKTX $1.31
- QTRX $4.67
- 52 Week High
- NKTX $8.53
- QTRX $19.18
- Technical
- Relative Strength Index (RSI)
- NKTX 50.34
- QTRX 38.14
- Support Level
- NKTX $1.42
- QTRX $4.67
- Resistance Level
- NKTX $1.99
- QTRX $5.73
- Average True Range (ATR)
- NKTX 0.19
- QTRX 0.55
- MACD
- NKTX 0.01
- QTRX -0.04
- Stochastic Oscillator
- NKTX 31.52
- QTRX 26.64
About NKTX Nkarta Inc.
Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells to treat cancer and autoimmune diseases. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer. The Company's operations are based in South San Francisco, California.
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.